Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04044430
Title Encorafenib, Binimetinib, and Nivolumab in Treating Patients With Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University of California, San Francisco
Indications

colon adenocarcinoma

rectum adenocarcinoma

Therapies

Binimetinib + Encorafenib + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST